2 Stocks Targeting Major Advances in Cancer and Eye Disease Treatments


Verastem, Inc. (VSTM)

Verastem is a biopharmaceutical company focused on developing therapies to treat cancer, including low-grade serous ovarian cancer and other difficult-to-treat tumors. Growth is driven by promising clinical trial data, strategic collaborations, and advancing its RAS-targeted therapy pipeline aimed at improving patient outcomes. Chart

Kodiak Sciences Inc (KOD)

Kodiak Sciences is a clinical-stage biopharma company developing therapies for retinal diseases. Growth is supported by its antibody biopolymer conjugate platform, which aims to extend dosing intervals and enhance durability. The company is advancing its pipeline through late-stage trials targeting high-need eye disorders. Chart


 


Follow Trade Ideas on


 
Trending Ideas

Featured Stocks On The Move

Featured Stocks On The Move